Dorothee Heinemeier
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Dorothee Heinemeier has a total of 56 co-authors. Here are the top co-authors by number of shared publications:
- Cornelia Betsch
Health Communication, Institute for Planetary Health Behaviour University of Erfurt Erfurt Germany
6 shared publications Cornelia Betsch
3 shared publications- Philipp Schmid
Centre for Language Studies, Radboud University, Nijmegen, The Netherlands
3 shared publications - Sarah Eitze
Institute for Planetary Health Behaviour, University Erfurt, Erfurt, Germany
3 shared publications Philipp Schmid
2 shared publications- Robert Böhm
Faculty of Psychology, University of Vienna
2 shared publications
Latest Publications
- Open Access
- 12 October 2026
- Published by American Psychological Association (APA) in Health Psychology
An extended knowledge intervention addressing vaccine hesitancy in the field: Results from two representative surveys.
- 12 October 2026
- Published by American Psychological Association (APA) in Health Psychology
Open AccessAn extended knowledge intervention addressing vaccine hesitancy in the field: Results from two representative surveys.
- Open Access
- 6 May 2025
- Published by Springer Nature in BMC Public Health
- Vol. 25 (1) , 1-17
Influenza and pneumococcal vaccine hesitancy in the elderly population: results from two representative surveys in Germany
Background: The reasons for low influenza and pneumococcal vaccine acceptance in the elderly population are largely unknown – despite the great need of vaccines in this risk group. While many studies examine the relationship between factors influencing vaccination, such as sociodemographic characteristics and influenza and pneumococcal vaccination intentions and behavior, psychological factors, such as vaccine-specific attitudes, are underutilized in research on vaccination behaviors and intervention strategies. This article assesses the psychological antecedents of influenza and pneumococcal vaccination in the elderly and assesses the predictive power of psychological vs. sociodemographic and other factors surrounding vaccination, on vaccination behavior. Methods: A cross-sectional telephone survey, representative of age, gender and rural/urban residence, was conducted with N = 701 German participants > 60 years of age, during the influenza season of 2016–17. Multiple logistic regressions were conducted to identify the relevant determinants of vaccination behavior. Results: Results show unique patterns in the psychological antecedents: while confidence, the belief in the effectiveness of vaccination and calculation, the need for information, complacency, the lack of risk perception and constraints, and perceived practical barriers to vaccination predicted influenza vaccination behavior, only complacency predicted pneumococcal vaccination behavior. The amount of explained variance in influenza vaccination behavior nearly doubles when psychological antecedents of vaccination are taken into account, beyond other factors surrounding vaccination. However, the effect was smaller for pneumococcal vaccination behavior. The results are compared to a subnational sample. Conclusions: Understanding the psychological drivers of vaccination can help to plan interventions effectively. Trial registration: Deutsches Register Klinische Studien (German Clinical Trials Register) DRKS00012653. Registered 24.11.2017. Retrospectively registered.
- 6 May 2025
- Published by Springer Nature in BMC Public Health
- Vol. 25 (1) , 1-17
Open AccessInfluenza and pneumococcal vaccine hesitancy in the elderly population: results from two representative surveys in Germany
Background: The reasons for low influenza and pneumococcal vaccine acceptance in the elderly population are largely unknown – despite the great need of vaccines in this risk group. While many studies examine the relationship between factors influencing vaccination, such as sociodemographic characteristics and influenza and pneumococcal vaccination intentions and behavior, psychological factors, such as vaccine-specific attitudes, are underutilized in research on vaccination behaviors and intervention strategies. This article assesses the psychological antecedents of influenza and pneumococcal vaccination in the elderly and assesses the predictive power of psychological vs. sociodemographic and other factors surrounding vaccination, on vaccination behavior. Methods: A cross-sectional telephone survey, representative of age, gender and rural/urban residence, was conducted with N = 701 German participants > 60 years of age, during the influenza season of 2016–17. Multiple logistic regressions were conducted to identify the relevant determinants of vaccination behavior. Results: Results show unique patterns in the psychological antecedents: while confidence, the belief in the effectiveness of vaccination and calculation, the need for information, complacency, the lack of risk perception and constraints, and perceived practical barriers to vaccination predicted influenza vaccination behavior, only complacency predicted pneumococcal vaccination behavior. The amount of explained variance in influenza vaccination behavior nearly doubles when psychological antecedents of vaccination are taken into account, beyond other factors surrounding vaccination. However, the effect was smaller for pneumococcal vaccination behavior. The results are compared to a subnational sample. Conclusions: Understanding the psychological drivers of vaccination can help to plan interventions effectively. Trial registration: Deutsches Register Klinische Studien (German Clinical Trials Register) DRKS00012653. Registered 24.11.2017. Retrospectively registered.
- Open Access
- 3 November 2023
- Published by Springer Nature in Research Square
Influenza and pneumococcal vaccine hesitancy in the elderly population: Results from two representative surveys in Germany
Background The reasons for low vaccine acceptance in the elderly population are largely unknown – despite the great need of vaccines in this risk group. Moreover, while many studies assess the impact of factors surrounding vaccination, such as sociodemographic information, psychological factors, such as vaccine-specific attitudes, are not sufficiently used in the research of vaccination behavior and interventions. This article assesses the psychological antecedents of influenza and pneumococcal vaccination in the elderly and assesses the relative impact of psychological vs. sociodemographic and other factors surrounding vaccination, on vaccination behavior. Methods A cross-sectional telephone survey, representative of age, gender and rural/urban residence, was conducted with N = 701 German participants > 60 years of age, during the influenza season of 2016–17. Multiple logistic regressions were conducted to identify the relevant determinants of vaccination behavior. Results Results show unique patterns in the psychological antecedents: while confidence, the belief in the effectiveness of vaccination and calculation, the need for information, complacency, the lack of risk perception and constraints, and perceived practical barriers to vaccination predicted influenza vaccination behavior, only complacency predicted pneumococcal vaccination behavior. The amount of explained variance in influenza vaccination behavior nearly doubles when psychological antecedents of vaccination are taken into account, beyond other factors surrounding vaccination. However, the effect was smaller for pneumococcal vaccination behavior. The results are compared to a subnational sample. Conclusions Understanding the psychological drivers of vaccination can help to plan interventions effectively. Trial registration: Deutsches Register Klinische Studien (German Clinical Trials Register) DRKS00012653. Registered 24.11.2017. Retrospectively registered.
- 3 November 2023
- Published by Springer Nature in Research Square
Open AccessInfluenza and pneumococcal vaccine hesitancy in the elderly population: Results from two representative surveys in Germany
Background The reasons for low vaccine acceptance in the elderly population are largely unknown – despite the great need of vaccines in this risk group. Moreover, while many studies assess the impact of factors surrounding vaccination, such as sociodemographic information, psychological factors, such as vaccine-specific attitudes, are not sufficiently used in the research of vaccination behavior and interventions. This article assesses the psychological antecedents of influenza and pneumococcal vaccination in the elderly and assesses the relative impact of psychological vs. sociodemographic and other factors surrounding vaccination, on vaccination behavior. Methods A cross-sectional telephone survey, representative of age, gender and rural/urban residence, was conducted with N = 701 German participants > 60 years of age, during the influenza season of 2016–17. Multiple logistic regressions were conducted to identify the relevant determinants of vaccination behavior. Results Results show unique patterns in the psychological antecedents: while confidence, the belief in the effectiveness of vaccination and calculation, the need for information, complacency, the lack of risk perception and constraints, and perceived practical barriers to vaccination predicted influenza vaccination behavior, only complacency predicted pneumococcal vaccination behavior. The amount of explained variance in influenza vaccination behavior nearly doubles when psychological antecedents of vaccination are taken into account, beyond other factors surrounding vaccination. However, the effect was smaller for pneumococcal vaccination behavior. The results are compared to a subnational sample. Conclusions Understanding the psychological drivers of vaccination can help to plan interventions effectively. Trial registration: Deutsches Register Klinische Studien (German Clinical Trials Register) DRKS00012653. Registered 24.11.2017. Retrospectively registered.
- Open Access
- 15 July 2023
- Published by Springer Nature in BMC Primary Care
- Vol. 24 (1) , 1-11
A complex intervention on vaccination uptake among older adults (≥ 60 years) in Germany – a study protocol with a mixed methods design
Background: The current uptake of many vaccinations recommended for persons aged 60 and older is unsatisfactory in Germany. Lack of confidence in the safety and efficacy of vaccinations, lack of knowledge and insecurities about possible side effects, and numerous pragmatic barriers are just some of the reasons to be mentioned. General practitioners (GPs) play a central role in the vaccination process. Therefore, effective interventions in this context are needed to address the various barriers and improve the vaccination uptake rates.Methods: A complex intervention will be implemented and evaluated in 1057 GPs’ practices in two German federal states. The components include trainings for GPs and medical assistants on communication psychology, medical aspects, and organisational vaccination processes. The primary outcome influenza vaccination rate and the secondary outcomes vaccination uptake rate of other vaccinations as well as vaccine literacy of patients will be examined. The intervention will be evaluated in a mixed methods study with a controlled design. Survey data will be analysed descriptively and by using mean comparisons as well as multivariable multilevel analyses. The qualitative data will be analysed with qualitative content analysis. The secondary data will be analysed by using descriptive statistics, a pre-post comparison by performing mean comparisons, cluster analysis, and subgroup analyses.Discussion: In this study, a complex intervention to improve vaccination rates in GP practices for the vaccinations recommended for people aged 60 years and older will be implemented and evaluated. Additionally, improvements in patients’ vaccine-related health literacy and knowledge, and patients’ intention to get vaccinated are expected. The mixed methods design can deliver results that can be used to improve preventive health care for elderly people and to gain more knowledge on vaccination uptake and the intervention’s effectiveness.Trial registration: Trial registration number: DRKS00027252 (retrospectively registered).
- 15 July 2023
- Published by Springer Nature in BMC Primary Care
- Vol. 24 (1) , 1-11
Open AccessA complex intervention on vaccination uptake among older adults (≥ 60 years) in Germany – a study protocol with a mixed methods design
Background: The current uptake of many vaccinations recommended for persons aged 60 and older is unsatisfactory in Germany. Lack of confidence in the safety and efficacy of vaccinations, lack of knowledge and insecurities about possible side effects, and numerous pragmatic barriers are just some of the reasons to be mentioned. General practitioners (GPs) play a central role in the vaccination process. Therefore, effective interventions in this context are needed to address the various barriers and improve the vaccination uptake rates.Methods: A complex intervention will be implemented and evaluated in 1057 GPs’ practices in two German federal states. The components include trainings for GPs and medical assistants on communication psychology, medical aspects, and organisational vaccination processes. The primary outcome influenza vaccination rate and the secondary outcomes vaccination uptake rate of other vaccinations as well as vaccine literacy of patients will be examined. The intervention will be evaluated in a mixed methods study with a controlled design. Survey data will be analysed descriptively and by using mean comparisons as well as multivariable multilevel analyses. The qualitative data will be analysed with qualitative content analysis. The secondary data will be analysed by using descriptive statistics, a pre-post comparison by performing mean comparisons, cluster analysis, and subgroup analyses.Discussion: In this study, a complex intervention to improve vaccination rates in GP practices for the vaccinations recommended for people aged 60 years and older will be implemented and evaluated. Additionally, improvements in patients’ vaccine-related health literacy and knowledge, and patients’ intention to get vaccinated are expected. The mixed methods design can deliver results that can be used to improve preventive health care for elderly people and to gain more knowledge on vaccination uptake and the intervention’s effectiveness.Trial registration: Trial registration number: DRKS00027252 (retrospectively registered).
- Open Access
- 5 August 2021
- Published by Springer Nature in Der Gynäkologe
- Vol. 54 (9) , 665-672
Impfverhalten psychologisch erklären und verändern am Beispiel der HPV-Impfung
Zusammenfassung: Impfmüdigkeit bezeichnet das Verzögern, Auslassen oder Ablehnen wichtiger Impfungen trotz ihrer Verfügbarkeit. Die Impfung gegen humane Papillomviren (HPV) schützt gegen verschiedene Varianten von Gebärmutterhalskrebs und wird für Mädchen und Jungen im Alter von 9–14 Jahren empfohlen. Allerdings sind die Impfquoten im Vergleich zu anderen Kinderimpfungen geringer, zudem zeigen sich deutliche Abbruchquoten zwischen Erst- und Zweitimpfung. Jährlich sterben rund 1500 Frauen in Deutschland und 311.000 Frauen weltweit an Gebärmutterhalskrebs. Eine Elimination des Gebärmutterhalskrebses bis zum Ende des Jahrhunderts wäre theoretisch möglich, und globale Strategien existieren, um dieses Ziel zu erreichen – dafür bräuchte es aber unter anderem deutlich höhere Impfquoten. Im Beitrag wird betrachtet, welche psychologischen Faktoren die HPV-Impfung begünstigen oder ihr im Weg stehen und was Ärztinnen und Ärzte tun können, um die Impfmotivation zu steigern.
- 5 August 2021
- Published by Springer Nature in Der Gynäkologe
- Vol. 54 (9) , 665-672
Open AccessImpfverhalten psychologisch erklären und verändern am Beispiel der HPV-Impfung
Zusammenfassung: Impfmüdigkeit bezeichnet das Verzögern, Auslassen oder Ablehnen wichtiger Impfungen trotz ihrer Verfügbarkeit. Die Impfung gegen humane Papillomviren (HPV) schützt gegen verschiedene Varianten von Gebärmutterhalskrebs und wird für Mädchen und Jungen im Alter von 9–14 Jahren empfohlen. Allerdings sind die Impfquoten im Vergleich zu anderen Kinderimpfungen geringer, zudem zeigen sich deutliche Abbruchquoten zwischen Erst- und Zweitimpfung. Jährlich sterben rund 1500 Frauen in Deutschland und 311.000 Frauen weltweit an Gebärmutterhalskrebs. Eine Elimination des Gebärmutterhalskrebses bis zum Ende des Jahrhunderts wäre theoretisch möglich, und globale Strategien existieren, um dieses Ziel zu erreichen – dafür bräuchte es aber unter anderem deutlich höhere Impfquoten. Im Beitrag wird betrachtet, welche psychologischen Faktoren die HPV-Impfung begünstigen oder ihr im Weg stehen und was Ärztinnen und Ärzte tun können, um die Impfmotivation zu steigern.
- 1 February 2021
- Published by American Psychological Association (APA) in Health Psychology
- Vol. 40 (2) , 77-88
Decreasing vaccine hesitancy with extended health knowledge: Evidence from a longitudinal randomized controlled trial.
This study assesses whether combining information about diseases and sequelae supports learning about disease risks and influences related health behavior (vaccination). To test whether extending knowledge about the risks of primary diseases (e.g., influenza) with causally linked secondary diseases (sequelae such as sepsis) can decrease vaccine hesitancy in older adults, who are especially vulnerable to primary and secondary diseases. In a preregistered longitudinal online experiment, 585 German participants > 60 years of age were randomly assigned to a 3 (time: before and after leaflet presentation, 3-month follow-up; within) × 3 (educational leaflet type: sepsis leaflet, traditional vaccination leaflet, and control leaflet; between) mixed-measurements design. The assessed outcomes were knowledge about influenza, pneumococci, and sepsis; risk perceptions; and immediate and long-term vaccination intention and behavior for pneumococcal and influenza vaccinations. The sepsis leaflet immediately increased the knowledge about influenza (effect size, η² = .080), pneumococci (η² = .071) and sepsis (η² = .113), risk perceptions (η² = .007), and intentions for both vaccinations (both η² = .015). Behavior during the follow-up did not differ between the conditions. Additional mediation analysis showed that increased knowledge immediately after the experiment predicted increased risk perceptions and intentions 3 months later (binfluenza = .060; bpneumococci = .055). Because immediate increases in knowledge and risk perceptions did not change behavior in the long term, extended knowledge interventions might be more effective in locations where positive intention can directly turn into action, such as doctors' clinics. (PsycInfo Database Record (c) 2021 APA, all rights reserved).
- 1 February 2021
- Published by American Psychological Association (APA) in Health Psychology
- Vol. 40 (2) , 77-88
Decreasing vaccine hesitancy with extended health knowledge: Evidence from a longitudinal randomized controlled trial.
This study assesses whether combining information about diseases and sequelae supports learning about disease risks and influences related health behavior (vaccination). To test whether extending knowledge about the risks of primary diseases (e.g., influenza) with causally linked secondary diseases (sequelae such as sepsis) can decrease vaccine hesitancy in older adults, who are especially vulnerable to primary and secondary diseases. In a preregistered longitudinal online experiment, 585 German participants > 60 years of age were randomly assigned to a 3 (time: before and after leaflet presentation, 3-month follow-up; within) × 3 (educational leaflet type: sepsis leaflet, traditional vaccination leaflet, and control leaflet; between) mixed-measurements design. The assessed outcomes were knowledge about influenza, pneumococci, and sepsis; risk perceptions; and immediate and long-term vaccination intention and behavior for pneumococcal and influenza vaccinations. The sepsis leaflet immediately increased the knowledge about influenza (effect size, η² = .080), pneumococci (η² = .071) and sepsis (η² = .113), risk perceptions (η² = .007), and intentions for both vaccinations (both η² = .015). Behavior during the follow-up did not differ between the conditions. Additional mediation analysis showed that increased knowledge immediately after the experiment predicted increased risk perceptions and intentions 3 months later (binfluenza = .060; bpneumococci = .055). Because immediate increases in knowledge and risk perceptions did not change behavior in the long term, extended knowledge interventions might be more effective in locations where positive intention can directly turn into action, such as doctors' clinics. (PsycInfo Database Record (c) 2021 APA, all rights reserved).
- Open Access
Sample study protocol for adapting and translating the 5C scale to assess the psychological antecedents of vaccination
Introduction Published in 2018, the 5C scale is psychometrically validated to assess five psychological antecedents of vaccination (confidence, complacency, constraints, calculation and collective responsibility). The original version offers a validated English and German scale to assess these determinants with a short 5-item scale (1 item per antecedent) and a long 15-item scale (3 items per antecedent). This sample study protocol provides a step-by-step guidance for the process of adapting the 5C scale to another country, language or cultural context. Data obtained from the 5C scale can support developing, implementing and evaluating an intervention and monitoring of general vaccine acceptance and demand. Methods and analysis Phase 1 comprises the adaptation of the 5C scale including the translation and back translation of the antecedents, an expert evaluation of the antecedents and the identification of new antecedents as well as a pretest. Phase 2 involves the validation of the translated and potentially expanded scale including the assessment of reliability, construct and concurrent validity of all items of the scale. Code for data analysis is provided. Ethics and dissemination The University of Erfurt’s institutional review board provided ethical clearance (EV-201900416.2). The authors suggest and encourage publicly sharing all data obtained from the translated 5C scale (eg, on publication). The materials and the code for data analysis to support the process described in this protocol are available in https://osf.io/2agxe/. Sharing data on vaccine acceptance and demand is in the public and the scientific interest and will facilitate gaining a global overview of its current state and development over time. The authors of the original 5C scale are currently working on an online platform to facilitate publishing the data and to visualise the psychological antecedents across different countries.
Open AccessSample study protocol for adapting and translating the 5C scale to assess the psychological antecedents of vaccination
Introduction Published in 2018, the 5C scale is psychometrically validated to assess five psychological antecedents of vaccination (confidence, complacency, constraints, calculation and collective responsibility). The original version offers a validated English and German scale to assess these determinants with a short 5-item scale (1 item per antecedent) and a long 15-item scale (3 items per antecedent). This sample study protocol provides a step-by-step guidance for the process of adapting the 5C scale to another country, language or cultural context. Data obtained from the 5C scale can support developing, implementing and evaluating an intervention and monitoring of general vaccine acceptance and demand. Methods and analysis Phase 1 comprises the adaptation of the 5C scale including the translation and back translation of the antecedents, an expert evaluation of the antecedents and the identification of new antecedents as well as a pretest. Phase 2 involves the validation of the translated and potentially expanded scale including the assessment of reliability, construct and concurrent validity of all items of the scale. Code for data analysis is provided. Ethics and dissemination The University of Erfurt’s institutional review board provided ethical clearance (EV-201900416.2). The authors suggest and encourage publicly sharing all data obtained from the translated 5C scale (eg, on publication). The materials and the code for data analysis to support the process described in this protocol are available in https://osf.io/2agxe/. Sharing data on vaccine acceptance and demand is in the public and the scientific interest and will facilitate gaining a global overview of its current state and development over time. The authors of the original 5C scale are currently working on an online platform to facilitate publishing the data and to visualise the psychological antecedents across different countries.
- Top Cited PapersOpen Access
- 7 December 2018
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 13 (12) , e0208601
Beyond confidence: Development of a measure assessing the 5C psychological antecedents of vaccination
Monitoring the reasons why a considerable number of people do not receive recommended vaccinations allows identification of important trends over time, and designing and evaluating strategies to address vaccine hesitancy and increase vaccine uptake. Existing validated measures assessing vaccine hesitancy focus primarily on confidence in vaccines and the system that delivers them. However, empirical and theoretical work has stated that complacency (not perceiving diseases as high risk), constraints (structural and psychological barriers), calculation (engagement in extensive information searching), and aspects pertaining to collective responsibility (willingness to protect others) also play a role in explaining vaccination behavior. The objective was therefore to develop a validated measure of these 5C psychological antecedents of vaccination. Three cross-sectional studies were conducted. Study 1 uses factor analysis to develop an initial scale and assesses the sub-scales’ convergent, discriminant, and concurrent validity (N = 1,445, two German convenience-samples). In Study 2, a sample representative regarding age and gender for the German population (N = 1,003) completed the measure for vaccination in general and for specific vaccinations to assess the potential need for a vaccine-specific wording of items. Study 3 compared the novel scale’s performance with six existing measures of vaccine hesitancy (N = 350, US convenience-sample). As an outcome, a long (15-item) and short (5-item) 5C scale were developed as reliable and valid indicators of confidence, complacency, constraints, calculation, and collective responsibility. The 5C sub-scales correlated with relevant psychological concepts, such as attitude (confidence), perceived personal health status and invulnerability (complacency), self-control (constraints), preference for deliberation (calculation), and communal orientation (collective responsibility), among others. The new scale provided similar results when formulated in a general vs. vaccine-specific way (Study 2). In a comparison of seven measures the 5C scale was constantly among the scales that explained the highest amounts of variance in analyses predicting single vaccinations (between 20% and 40%; Study 3). The present studies are limited to the concurrent validity of the scales. The 5C scale provides a novel tool to monitor psychological antecedents of vaccination and facilitates diagnosis, intervention design and evaluation. Its short version is suitable for field settings and regular global monitoring of relevant antecedents of vaccination.
- 7 December 2018
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 13 (12) , e0208601
Top Cited PapersOpen AccessBeyond confidence: Development of a measure assessing the 5C psychological antecedents of vaccination
Monitoring the reasons why a considerable number of people do not receive recommended vaccinations allows identification of important trends over time, and designing and evaluating strategies to address vaccine hesitancy and increase vaccine uptake. Existing validated measures assessing vaccine hesitancy focus primarily on confidence in vaccines and the system that delivers them. However, empirical and theoretical work has stated that complacency (not perceiving diseases as high risk), constraints (structural and psychological barriers), calculation (engagement in extensive information searching), and aspects pertaining to collective responsibility (willingness to protect others) also play a role in explaining vaccination behavior. The objective was therefore to develop a validated measure of these 5C psychological antecedents of vaccination. Three cross-sectional studies were conducted. Study 1 uses factor analysis to develop an initial scale and assesses the sub-scales’ convergent, discriminant, and concurrent validity (N = 1,445, two German convenience-samples). In Study 2, a sample representative regarding age and gender for the German population (N = 1,003) completed the measure for vaccination in general and for specific vaccinations to assess the potential need for a vaccine-specific wording of items. Study 3 compared the novel scale’s performance with six existing measures of vaccine hesitancy (N = 350, US convenience-sample). As an outcome, a long (15-item) and short (5-item) 5C scale were developed as reliable and valid indicators of confidence, complacency, constraints, calculation, and collective responsibility. The 5C sub-scales correlated with relevant psychological concepts, such as attitude (confidence), perceived personal health status and invulnerability (complacency), self-control (constraints), preference for deliberation (calculation), and communal orientation (collective responsibility), among others. The new scale provided similar results when formulated in a general vs. vaccine-specific way (Study 2). In a comparison of seven measures the 5C scale was constantly among the scales that explained the highest amounts of variance in analyses predicting single vaccinations (between 20% and 40%; Study 3). The present studies are limited to the concurrent validity of the scales. The 5C scale provides a novel tool to monitor psychological antecedents of vaccination and facilitates diagnosis, intervention design and evaluation. Its short version is suitable for field settings and regular global monitoring of relevant antecedents of vaccination.
- Open Access
- 16 July 2018
- Published by Springer Nature in BMC Public Health
- Vol. 18 (1) , 885
Increasing influenza and pneumococcal vaccine uptake in the elderly: study protocol for the multi-methods prospective intervention study Vaccination60+
Influenza and pneumococcal vaccination can prevent disease and potentially life-threatening complications like sepsis. Elderly people have an increased risk of severe disease and therefore constitute a major target group for vaccination. To increase vaccination coverage, targeted interventions are needed that take theory-based specific determinants of vaccination behaviour into account. Moreover, message and campaign design should consider specific age-related characteristics (e.g., information processing, media use). The aim of this study is (i) to identify the specific informational and interventional needs of this risk group, (ii) to design and implement a targeted intervention aiming to decrease vaccine hesitancy, increase vaccine uptake and decrease the health and economic burden due to the respective diseases, and (iii) to measure the effect of this evidence-informed intervention on various levels. Prospective, multi-methods intervention study targeting individuals aged ≥60 years in a model region in Germany (federal state of Thuringia, 500,000 inhabitants ≥60 years old). The development of the intervention follows theory-based and evidence-informed principles: Data from a cross-sectional representative study provide insights into specific determinants of the target group’s vaccination behaviour. Additionally, media use is analysed to identify adequate communication channels for specific subgroups. In pilot studies, the intervention materials are adapted to the specific cognitive requirements of the target group. For development and implementation of the intervention, an interdisciplinary and trans-sectoral approach is used, including psychology, communication science, design, medical science, epidemiology and various public health players. The intervention will be implemented in autumn and winter 2017/18 and 2018/19 and adjusted in between. Evaluation of the intervention includes: awareness, use and recall of intervention materials, effects on changes in determinants of vaccination behaviour, self-reported vaccine uptake, and vaccination coverage in the intervention area (primary outcomes), as well as disease incidences (secondary outcomes) and the economic burden of influenza, pneumonia, invasive pneumococcal disease and sepsis for the healthcare system (tertiary outcomes). The data will add to the body of evidence on the effectiveness of evidence-informed vaccination campaign development as well as on the clinical and economic effects of pneumococcal and influenza vaccination. The effect of the intervention will teach valuable lessons about the principles of campaign development and evaluation, and can motivate a subsequent nationwide intervention. DRKS00012653 . Registered 24.11.2017. Retrospectively registered.
- 16 July 2018
- Published by Springer Nature in BMC Public Health
- Vol. 18 (1) , 885
Open AccessIncreasing influenza and pneumococcal vaccine uptake in the elderly: study protocol for the multi-methods prospective intervention study Vaccination60+
Influenza and pneumococcal vaccination can prevent disease and potentially life-threatening complications like sepsis. Elderly people have an increased risk of severe disease and therefore constitute a major target group for vaccination. To increase vaccination coverage, targeted interventions are needed that take theory-based specific determinants of vaccination behaviour into account. Moreover, message and campaign design should consider specific age-related characteristics (e.g., information processing, media use). The aim of this study is (i) to identify the specific informational and interventional needs of this risk group, (ii) to design and implement a targeted intervention aiming to decrease vaccine hesitancy, increase vaccine uptake and decrease the health and economic burden due to the respective diseases, and (iii) to measure the effect of this evidence-informed intervention on various levels. Prospective, multi-methods intervention study targeting individuals aged ≥60 years in a model region in Germany (federal state of Thuringia, 500,000 inhabitants ≥60 years old). The development of the intervention follows theory-based and evidence-informed principles: Data from a cross-sectional representative study provide insights into specific determinants of the target group’s vaccination behaviour. Additionally, media use is analysed to identify adequate communication channels for specific subgroups. In pilot studies, the intervention materials are adapted to the specific cognitive requirements of the target group. For development and implementation of the intervention, an interdisciplinary and trans-sectoral approach is used, including psychology, communication science, design, medical science, epidemiology and various public health players. The intervention will be implemented in autumn and winter 2017/18 and 2018/19 and adjusted in between. Evaluation of the intervention includes: awareness, use and recall of intervention materials, effects on changes in determinants of vaccination behaviour, self-reported vaccine uptake, and vaccination coverage in the intervention area (primary outcomes), as well as disease incidences (secondary outcomes) and the economic burden of influenza, pneumonia, invasive pneumococcal disease and sepsis for the healthcare system (tertiary outcomes). The data will add to the body of evidence on the effectiveness of evidence-informed vaccination campaign development as well as on the clinical and economic effects of pneumococcal and influenza vaccination. The effect of the intervention will teach valuable lessons about the principles of campaign development and evaluation, and can motivate a subsequent nationwide intervention. DRKS00012653 . Registered 24.11.2017. Retrospectively registered.
- Open Access
- 1 January 2018
- Published by Nomos Verlag
- p. 45-60
Was bedeutet Evidenzbasierung / Evidenzinformierung in der Gesundheitskommunikation? Eine Befragung während der 2. Jahrestagung der Fachgruppe Gesundheitskommunikation der DGPuK
- 1 January 2018
- Published by Nomos Verlag
- p. 45-60
Open AccessWas bedeutet Evidenzbasierung / Evidenzinformierung in der Gesundheitskommunikation? Eine Befragung während der 2. Jahrestagung der Fachgruppe Gesundheitskommunikation der DGPuK